Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917097 · ClinicalTrials.gov registry record
Bradycardia Following Intraoperative Administration of Dexmedetomidine
A clinical trial, sponsored by Joseph D. Tobias.
- Completed
- Registry status
- 921
- Enrollment target
NCT01917097: Completed study, sponsored by Joseph D. Tobias.
NCT01917097 is a clinical trial that has completed, run by Joseph D. Tobias. The registered enrollment target is 921 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01917097 has completed, sponsored by Joseph D. Tobias.
- COMPLETED
- Registry status
- 921 participants
- Enrollment target
Study Summary
This is a retrospective chart review to evaluate the postoperative course of all pediatric patients admitted to the hospital following adenotonsillectomy over the past 24 months to evaluate the incidence of bradycardia in children who received dexmedetomidine intraoperatively and identify confounding factors which may be precipitating the bradycardia or potentiating the negative chronotropic effects of dexmedetomidine.
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 921 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-06 |
What the finished NCT01917097 record still lists
NCT01917097 is an observational study that tracks outcomes without assigning an intervention. The registered 921 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT01917097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01917097 about?
NCT01917097 is a clinical study titled "Bradycardia Following Intraoperative Administration of Dexmedetomidine". This is a retrospective chart review to evaluate the postoperative course of all pediatric patients admitted to the hospital following adenotonsillectomy over the past 24 months to evaluate the incidence of bradycardia in children who received dexmedetomidine intraoperatively and identify confoundin...
What is the current status of trial NCT01917097?
This trial is currently completed. The enrollment target is 921 participants. The study started on 2013-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01917097?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT01917097?
This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07151001 · 922 participants
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia